Publication | Closed Access

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis

Adverse EventsMedicineRetrospective Multicenter AnalysisClinical TrialsImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences